Mechanistic Determinants of Daprodustat Drug–Drug Interactions and Pharmacokinetics in Hepatic Dysfunction and Chronic Kidney Disease: Significance of OATP1B‐CYP2C8 Interplay

药理学 药代动力学 肾脏疾病 药物代谢 药品 医学 肝功能不全 内科学
作者
Yi‐An Bi,Samantha Jordan,Amanda King‐Ahmad,Mark A. West,Manthena V. S. Varma
出处
期刊:Clinical Pharmacology & Therapeutics [Wiley]
卷期号:115 (6): 1336-1345 被引量:3
标识
DOI:10.1002/cpt.3215
摘要

Daprodustat is the first oral hypoxia-inducible factor prolyl hydroxylase inhibitor approved recently for the treatment of anemia caused by chronic kidney disease (CKD) in adults receiving dialysis. We evaluated the role of organic anion transporting polypeptide (OATP)1B-mediated hepatic uptake transport in the pharmacokinetics (PKs) of daprodustat using in vitro and in vivo studies, and physiologically-based PK (PBPK) modeling of its drug-drug interactions (DDIs) with inhibitor drugs. In vitro, daprodustat showed specific transport by OATP1B1/1B3 in the transfected cell systems and primary human and monkey hepatocytes. A single-dose oral rifampin (OATP1B inhibitor) reduced daprodustat intravenous clearance by a notable 9.9 ± 1.2-fold (P < 0.05) in cynomolgus monkeys. Correspondingly, volume of distribution at steady-state was also reduced by 5.0 ± 1.1-fold, whereas the half-life change was minimal (1.5-fold), corroborating daprodustat hepatic uptake inhibition by rifampin. A PBPK model accounting for OATP1B-CYP2C8 interplay was developed, which well described daprodustat PK and DDIs with gemfibrozil (CYP2C8 and OATP1B inhibitor) and trimethoprim (weak CYP2C8 inhibitor) within 25% error of the observed data in healthy subjects. About 18-fold increase in daprodustat area under the curve (AUC) following gemfibrozil treatment was found to be associated with strong CYP2C8 inhibition and moderate OATP1B inhibition. Moreover, PK modulation in hepatic dysfunction and subjects with CKD, in comparison to healthy control, was well-captured by the model. CYP2C8 and/or OATP1B inhibitor drugs (e.g., gemfibrozil, clopidogrel, rifampin, and cyclosporine) were predicted to perpetrate moderate-to-strong DDIs in healthy subjects, as well as, in target CKD population. Daprodustat can be used as a sensitive CYP2C8 index substrate in the absence of OATP1B modulation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
QQ完成签到,获得积分10
3秒前
蔚欢发布了新的文献求助10
5秒前
7秒前
Akim应助罗拉采纳,获得10
8秒前
丘比特应助Heartlark采纳,获得10
8秒前
8秒前
延文星完成签到,获得积分20
10秒前
11秒前
xyj6486发布了新的文献求助10
11秒前
13秒前
13秒前
13秒前
bkagyin应助shao采纳,获得10
13秒前
糟糕的日记本完成签到,获得积分10
13秒前
蔚欢完成签到,获得积分10
14秒前
mx发布了新的文献求助10
16秒前
一川烟叶完成签到,获得积分10
16秒前
17秒前
时尚俊驰发布了新的文献求助10
18秒前
18秒前
整齐小松鼠应助mini采纳,获得10
20秒前
恋雅颖月应助liii采纳,获得10
22秒前
罗拉发布了新的文献求助10
24秒前
persist完成签到,获得积分10
25秒前
讨厌科研发布了新的文献求助10
25秒前
沉默曼文发布了新的文献求助40
26秒前
研友_VZG7GZ应助如梦如幻91采纳,获得10
26秒前
27秒前
充电宝应助mx采纳,获得10
28秒前
隐形曼青应助时尚俊驰采纳,获得10
29秒前
30秒前
量子星尘发布了新的文献求助10
30秒前
科研通AI5应助文献采纳,获得30
33秒前
cyan关注了科研通微信公众号
33秒前
34秒前
Qi发布了新的文献求助10
34秒前
领导范儿应助张钦奎采纳,获得10
35秒前
shao完成签到,获得积分10
35秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989378
求助须知:如何正确求助?哪些是违规求助? 3531442
关于积分的说明 11254002
捐赠科研通 3270126
什么是DOI,文献DOI怎么找? 1804887
邀请新用户注册赠送积分活动 882087
科研通“疑难数据库(出版商)”最低求助积分说明 809173